Nemera designs and manufactures drug delivery devices and combination drug-device solutions for pharmaceutical, biotechnology and generic manufacturers. The company operates across five delivery routes: ophthalmic, nasal/buccal/auricular spray systems, inhalation devices, dermal and transdermal dispensers, and parenteral devices including auto-injectors and pens. It serves clients from early device strategy through manufacturing and scales to over a billion devices sold annually across 54 countries.
Founded in 2014 from Montagu's acquisition of Rexam's healthcare and retail prescription divisions, Nemera is headquartered in Lyon, France, with production facilities in France, Germany, Poland, the United States, and Brazil. The company's technical expertise spans device design, combination products, ergonomics, accurate dosing, and state-of-the-art manufacturing practices.
